Test Code LAB2928 Diabetes Mellitus Type 1 Evaluation, Serum
Additional Codes
SQ: DIAEVA
MAYO: DBS1
Secondary ID
48400Useful For
Distinguishing type 1 from type 2 diabetes mellitus
Identifying individuals at risk of type 1 diabetes (including high-risk relatives of patients with diabetes)
Predicting future insulin requirement treatment in patients with adult-onset diabetes
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
DMEI | Diabetes Interpretation, S | No | Yes |
GD65S | GAD65 Ab Assay, S | Yes | Yes |
INAB | Insulin Abs, S | Yes | Yes |
IA2 | IA-2 Ab, S | Yes | Yes |
EZNT8 | ZnT8 Ab, S | Yes | Yes |
Method Name
GD65S, INAB, IA2: Radioimmunoassay (RIA)
EZNT8: Enzyme-Linked Immunosorbent Assay (ELISA)
DMEI: Interpretive Comments
Reporting Name
Diabetes Mellitus Type 1 EvaluationSpecimen Type
SerumSpecimen Required
Collection Container/Tube:
Preferred: Red top
Acceptable: Serum gel
Submission Container/Tube: Plastic vial
Specimen Volume: 4 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Specimen Minimum Volume
2 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 28 days | |
Frozen | 28 days | ||
Ambient | 72 hours |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | Reject |
Gross icterus | Reject |
Reference Values
GLUTAMIC ACID DECARBOXYLASE (GAD65) ANTIBODY
≤0.02 nmol/L
Reference values apply to all ages.
INSULIN ANTIBODIES
≤0.02 nmol/L
Reference values apply to all ages.
ISLET ANTIGEN 2 (IA-2) ANTIBODY
≤0.02 nmol/L
Reference values apply to all ages.
ZINC TRANSPORTER 8 (ZnT8) ANTIBODY
< 15.0 U/mL
Reference values apply to all ages.
Method Description
Radioimmunoassay:
(125)I-labeled recombinant human antigen is incubated with patient sample. Anti-human IgG is then added to form an immunoprecipitate. After washing the immunoprecipitate, the amount of (125)I-labeled antigen in the immunoprecipitate is measured using a gamma-counter. The amount of gamma emission in the precipitate is proportional to the amount of antigen-specific IgG in the sample. Results are reported as units of precipitated antigen (nMol) per L of patient sample.(Masuda M, Powell M, Chen S, et al. Autoantibodies to IA-2 in insulin-dependent diabetes mellitus. Measurements with a new immunoprecipitation assay. Clin Chim Acta. 2000;291(1):53-66; Walikonis JE, Lennon VA. Radioimmunoassay for glutamic acid decarboxylase [GAD65] autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus. Mayo Clin Proc. 1998;73[12]:1161-1166; Horta ES, Lennon VA, Lachance DH, et al. Neural autoantibody clusters aid diagnosis of cancer. Clin Cancer Res. 2014;20[14]:3862-9386)
Enzyme-Linked Immunosorbent Assay
Zinc transporter 8 (ZnT8) antibodies are principally directed against the C terminal domain of ZnT8. The ZnT8 autoantibody enzyme-linked immunosorbent assay is based on the bridging principle that employs the ability of divalent ZnT8 autoantibodies to bind to ZnT8 coated on to the plate well with one arm, and to liquid ZnT8-biotin with the other arm. Calibrators or undiluted samples in duplicate are added to ZnT8 coated plate wells and incubated overnight. ZnT8-biotin is added to each well and plates. After further incubation, aspiration, and wash, streptavidin-peroxidase is added to each well. After further incubation, aspiration, and wash, peroxidase substrate is added. After further incubation, 0.5 mol/L sulfuric acid stop solution is added to each well. Absorbance is measured at 450nm, blanked against wells containing peroxidase substrate and sulfuric acid only.(Petruzelkova L, Ananieva-Jordanova R, Vcelakova J, et al. The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus. Diabet Med. 2014;31(2):165-171)
Day(s) Performed
GAD65 antibody: Monday through Friday
Insulin antibodies: Monday, Wednesday, Friday
IA-2 antibody, Zinc Transporter 8 Antibody: Tuesday, Thursday
Report Available
7 to 10 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
See Individual Test IDsCPT Code Information
86337
86341 x3
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
DBS1 | Diabetes Mellitus Type 1 Evaluation | 104673-9 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
81596 | GAD65 Ab Assay, S | 30347-9 |
89588 | IA-2 Ab, S | 81155-4 |
8666 | Insulin Abs, S | 60463-7 |
34268 | Diabetes Interpretation, S | 69048-7 |
64926 | ZnT8 Ab, S | 76651-9 |